SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010842
Filing Date
2019-11-12
Accepted
2019-11-12 17:02:16
Documents
63
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q morf-20190930x10q.htm 10-Q 2606893
2 EX-31.1 morf-20190930ex3118633d4.htm EX-31.1 13799
3 EX-31.2 morf-20190930ex312558989.htm EX-31.2 13687
4 EX-32.1 morf-20190930ex3210b975e.htm EX-32.1 8602
5 EX-32.2 morf-20190930ex32299ee3a.htm EX-32.2 7733
  Complete submission text file 0001558370-19-010842.txt   6965756

Data Files

Seq Description Document Type Size
6 EX-101.INS morf-20190930.xml EX-101.INS 1184412
7 EX-101.SCH morf-20190930.xsd EX-101.SCH 40125
8 EX-101.CAL morf-20190930_cal.xml EX-101.CAL 47013
9 EX-101.DEF morf-20190930_def.xml EX-101.DEF 189327
10 EX-101.LAB morf-20190930_lab.xml EX-101.LAB 412069
11 EX-101.PRE morf-20190930_pre.xml EX-101.PRE 325667
Mailing Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451 9787296480
Morphic Holding, Inc. (Filer) CIK: 0001679363 (see all company filings)

IRS No.: 473878772 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38940 | Film No.: 191210604
SIC: 2834 Pharmaceutical Preparations